Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
19.44 USD | -0.74% | -4.08% | +11.17% |
04-23 | Kiniksa Pharmaceuticals Q1 Loss Widens, Revenue Rises | MT |
04-23 | Transcript : Kiniksa Pharmaceuticals, Ltd., Q1 2024 Earnings Call, Apr 23, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.17% | 1.39B | |
+4.54% | 111B | |
+11.60% | 105B | |
-12.82% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.02% | 16.96B | |
+3.54% | 13.7B | |
+37.74% | 12.45B |
- Stock Market
- Equities
- KNSA Stock
- News Kiniksa Pharmaceuticals, Ltd.
- - (KNSA) KINIKSA PHARMACEUTICALS Q2 EPS $0.21